CINC insider filings
CinCor Pharma, Inc. — 10 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-02-28. Screen CINC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CINC between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — CinCor Pharma, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-02-28 | 4 | 5AM Partners VI, LLC — 10% owner 5AM Ventures VI, L.P. — 10% owner 5AM Opportunities I, L.P. — 10% owner Schwab Andrew J. — 10% owner PARMAR KUSH — 10% owner 5AM Opportunities II (GP), LLC — 10% owner 5AM Opportunities II, L.P. — 10% owner 5AM Opportunities I (GP), LLC — 10% owner | Code (U): 3,953,990 · Code (U): 487,333 · Code (U): 496,323 | EDGAR |
| 2023-02-27 | 4 | Freeman Mason — Chief Medical Officer | Sale (S): 6 @ $15.21 · Code (U): 2,494 · Disposition to issuer (D): 40,000 · Code (U): 100 · Disposition to issuer (D): 30,178 (derivative) · Disposition to issuer (D): 145,296 (derivative) · +1 more | EDGAR |
| 2023-02-27 | 4 | HEALY JAMES — Director, 10% owner Katabi Maha — 10% owner Sofinnova Management X, L.P. — 10% owner Sofinnova Management X-A, L.L.C. — 10% owner Sofinnova Venture Partners X, L.P. — 10% owner | Sale (S): 6,000 @ $14.32 · Code (U): 9,803 · Disposition to issuer (D): 19,608 · Code (U): 6,073,949 | EDGAR |
| 2023-02-24 | 4 | Allison David D. — Director | Disposition to issuer (D): 29,411 (derivative) · Disposition to issuer (D): 1,038 (derivative) · Disposition to issuer (D): 881 (derivative) · Disposition to issuer (D): 524 (derivative) · Disposition to issuer (D): 1,499 (derivative) | EDGAR |
| 2023-02-24 | 4 | Pearce Catherine — Chief Operating Officer | Code (U): 140,149 · Disposition to issuer (D): 15,000 · Code (U): 1,500 · Disposition to issuer (D): 110,136 (derivative) · Disposition to issuer (D): 13,236 (derivative) | EDGAR |
| 2023-02-24 | 4 | de Garidel Marc — Chief Executive Officer, Director | Code (U): 12,500 · Disposition to issuer (D): 200,000 · Disposition to issuer (D): 726,483 (derivative) · Disposition to issuer (D): 601,901 (derivative) | EDGAR |
| 2023-02-24 | 4 | Lee June — Director | Disposition to issuer (D): 47,954 (derivative) | EDGAR |
| 2023-02-24 | 4 | Kalb Michael Wayne — EVP & Chief Financial Officer | Disposition to issuer (D): 202,437 · Disposition to issuer (D): 77,615 (derivative) | EDGAR |
| 2023-02-24 | 4 | Ignelzi Troy A. — Director | Disposition to issuer (D): 36,324 (derivative) · Disposition to issuer (D): 58,823 (derivative) | EDGAR |
| 2023-02-24 | 4 | THERO JOHN F — Director | Disposition to issuer (D): 36,324 (derivative) · Disposition to issuer (D): 58,823 (derivative) | EDGAR |
Recent 8-K events — CinCor Pharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-02-24 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-02-21 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CINC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →